BioLargo Initiates Alpha Testing of Verralize's Portable PFAS Test Kit to Validate Performance for Future Commercialization July 1, 2025
Independent Evaluation Confirms Breakthrough Performance of BioLargo's Cellinity Battery Technology for Grid-Scale Energy Storage June 18, 2025
BioLargo Subsidiary Clyra Medical Advances Product Distribution Through a Series of Agreements May 13, 2025
BioLargo's PFAS Solution Provides Dramatic Long-Term Cost Savings Compared with Incumbent Technologies May 5, 2025
